(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

New study results demonstrated the safety and efficacy of the MannKind Afrezza inhaled insulin offering for children with ...

One of the leaders in continuous glucose monitoring (CGM) technology, Dexcom (Nadsaq:DXCM) continues to expand its ...

It's been a busy couple of years for Tandem Diabetes Care (Nasdaq:TNDM) and it doesn't look like slowing down any time soon.

Dexcom (Nasdaq:DXCM) has shared a new report highlighting access and attitudes toward type 2 diabetes in the U.S.

Sequel Medtech said at the American Diabetes Association's 85th Scientific Sessions that it plans to launch its twiist system ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

Medtronic (NYSE:MDT) today shared data supporting the use of its MiniMed 780G automated insulin delivery system in a range of ...

A new study showed improved glucose control in pregnant women using Tandem Diabetes Care (Nasdaq:TNDM) insulin delivery ...

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...

Beta Bionics (Nasdaq:BBNX) announced that it agreed to integrate its iLet bionic pancreas with a future dual sensor from ...

Ypsomed and CamDiab announced that they agreed to integrate their mylife Loop automated insulin delivery system with a future ...